Company Active LTD

Company profile

Revivocell Limited

Revivocell Limited | Next dimension Organ-on-a-Chip technology

Revivocell is a UK spin-out from Lancaster University based at Sci-Tech Daresbury Science Incubator Hub, Warrington. We develop cell culture technology to improve life sciences research and enhance drug discovery success. We want to enable scientists to be more creative in their research

CRN
09444997
Founded
2015
Age
11

Overview

Legal name
REVIVOCELL LIMITED
Region
North West England
Registered address
I-TAC BIO KECKWICK LANE
DARESBURY
WARRINGTON
ENGLAND
WA4 4AD
Insolvency history
No

Latest accounts

Financial period: 1 Mar 2024 to 28 Feb 2025

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
4

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Nov
2026

Accounts due

Accounts Due

Next accounts due date

05 Sep
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

22 Aug
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

28 Feb
2025

Accounts filed

Accounts

Last accounts made up date

23 Aug
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQzMzIzODA3NmFkaXF6a2N4

Published 23 Aug 2024 11:11

17 Feb
2015

Incorporated

Inception

Company registered at Companies House

Public funding

6 awards
First funded
2015
Funded years
2015, 2017, 2018, 2022
Age at first award
0 years

Projects

2022 Collaborative R&D Lead participant

A novel Liver & Brain multi-organ-chip model : rapid and reduced cost pre-clinical safety drug screening

1 Sep 2022 to 29 Feb 2024

Awarded
£263,332
Total cost £376,189

Cell culture involves the growth of living cells in laboratory conditions without using animals in order to gain better understanding of body function, disease or to develop new drugs. Conventionally, cells are grown in 2-D glass or plastic surfaces such as Petri-dishes and plates, and are normally cultured in isolation, ignoring multiple cell types impor...

2018 Feasibility Studies Lead participant

"CELLBLOKS" - A novel 3-D liver model platform to predict human drug-induced liver injury (DILI)

1 Aug 2018 to 31 Oct 2019

Awarded
£69,722
Total cost £99,605

"Drug-induced liver injury (DILI) is one of the leading cause of drug failure during development as well as number one cause of post-market drug withdrawal. There is a need for a more predictive tools to assess liver toxicity risks early in drug discovery. Human cell based laboratory models for safety screening are increasingly being developed as alternat...

2017 Feasibility Studies Lead participant

CELLBLOKS - A Novel Cell Culture Device

1 Jun 2017 to 31 May 2018

Awarded
£66,633
Total cost £95,230

Cell culture is a process whereby living cells are grown in laboratory conditions without using animals in order to gain better understanding of body function, disease or to develop new drugs. Traditionally, cells have been grown in hard and flat 2-D surfaces, either in glass or plastic, a technology that has not changed significantly since the invention ...

2017 Feasibility Studies Lead participant

Combined Novel 3-D Cell Culture and Biospectroscopy; personalising Osteoporosis therapeutics

1 Feb 2017 to 31 Mar 2018

Awarded
£68,543
Total cost £97,919

Osteoporosis is an incredibly debilitating disease. More than 3 million people in the UK are estimated to suffer and it effects 1 in 2 women and 1 in 5 men over the age of 50. It leads to increased risk of bone fractures, reduced quality of life and increased morbidity and mortality. More that 40% of people who experience fractures live with long-term pai...

2015 GRD Proof of Market Lead participant

Cellblocks - novel cell culture device

1 Aug 2015 to 31 Jan 2016

Awarded
£24,109
Total cost £40,182

Cell culture is a process whereby living cells are grown in laboratory conditions for various scientific experiments, without using animals, for example: to gain better understanding of bodily function, disease processes or to develop new drugs. Traditionally, cells have been grown in hard and flat 2-D (two-dimensional) surfaces, either in glass or plasti...

2015 Vouchers Lead participant

Novel tissue culture device

1 May 2015 to 31 Oct 2015

Awarded
£5,000
Total cost £5,000

Cell culture is a process where living cells are cultured in the laboratory setting without using animals for various scientific experiments including to understanding body function, disease and to develop new drugs. Traditionally, cells have been grown in hard and flat 2D surface such as in glass or plastic and this technology has not changed significant...

Product types

Collaborative R&D Feasibility Studies GRD Proof of Market Vouchers